The global Hutchinson-Gilford Progeria Syndrome market size was valued at USD 118.2 million in 2025 and is projected to reach USD 127.6 million in 2026, expanding to USD 218.4 million by 2034, growing at a CAGR of 6.8% during the forecast period (2026-2034).
Read More
The global hypereosinophilic syndrome market size was valued at USD 763 million in 2025 and is projected to reach USD 887 million in 2026, expanding to USD 1.96 billion by 2036, growing at a CAGR of 8.68% during the forecast period (2026-2036).
Read More
The global hypokalemic periodic paralysis treatment market was valued at USD 1.89 billion in 2025 and is projected to reach USD 2.14 billion in 2026, expanding to USD 4.18 billion by 2034, growing at a CAGR of 8.9% during the forecast period (2026-2034).
Read More
It is estimated that the global hypophosphatasia treatment market will grow at 8.5% CAGR in the forecast period to reach USD 1.8 billion by 2034, with approximately USD 997 million worth of sales in 2026.
Read More
The global ichthyosis market size was valued at USD 430.5 million in 2025 and is projected to reach USD 460.8 million in 2026, expanding to USD 814.6 million by 2034, growing at a CAGR of 7.4% during the forecast period (2026-2034).
Read More
The global immunodeficiencies market size was valued at USD 15.2 billion in 2025 and is projected to reach USD 16.5 billion in 2026, expanding to USD 31.8 billion by 2034, growing at a CAGR of 8.5% during the forecast period (2026-2034).
Read More
The global incontinentia pigmenti market was valued at USD 187.3 million in 2025 and is expected to reach USD 200.6 million in 2026, expanding further to USD 345.0 million by 2034, registering a CAGR of 7.1% during the forecast period (2026-2034).
Read More
The global infantile myofibrillar myopathy (MFM) market was valued at USD 185.2 million in 2025 and is projected to reach USD 206.5 million in 2026, expanding to USD 492.6 million by 2034, growing at a CAGR of 11.5% during the forecast period (2026-2034).
Read More
The global hemophagocytic lymphohistiocytosis (HLH) market was valued at USD 665 million in 2025 and is projected to reach USD 718 million in 2026, expanding to USD 1.32 billion by 2034, growing at a CAGR of 8.1% during the forecast period (2026-2034).
Read More
The size of the opsoclonus-myoclonus syndrome global market was valued at US $245 million in 2025 and is forecasted to reach US $264 million by 2026 while growing to US $480 million by 2034 in a CAGR of 7.8% from 2026 to 2034.
Read More
The global market for osteogenesis imperfecta was valued at $1.2 billion in 2025 and is projected to be worth $1.35 billion by 2026, while further growing to $3.0 billion by 2034, at a CAGR of 10.5 percent during the projection period (2026-2034).
Read More
The global Pantothenate Kinase-Associated Neurodegeneration (PKAN) market, estimated to be worth $195 million in 2025, is expected to grow to $216 million in 2026 and reach nearly $480 million by 2034, exhibiting a CAGR of 10.5% during the forecast period (2026-2034).
Read More
The global hereditary angioedema market size was valued at USD 3.8 billion in 2025 and is projected to reach USD 4.2 billion in 2026, expanding to USD 8.6 billion by 2034, growing at a CAGR of 9.4% during the forecast period (2026-2034).
Read More
The global Hermansky-Pudlak syndrome (HPS) market size was valued at USD 148.6 million in 2025 and is projected to reach USD 160.4 million in 2026, expanding to USD 308.0 million by 2034, growing at a CAGR of 8.5% during the forecast period (2026-2034).
Read More
The global Hurler syndrome market size was valued at USD 480 million in 2025 and is projected to reach USD 525 million in 2026, expanding to USD 1.08 billion by 2034, growing at a CAGR of 9.4% during the forecast period (2026-2034).
Read More
Valued at USD 44.8 million in 2025 and expected to grow to USD 48.6 million in 2026, the global Gerstmann-Strussler-Scheinker (GSS) syndrome market is projected to expand to approximately USD 98.3 million by 2034, growing at a CAGR of 9.2% during the forecast period (2026-2034).
Read More
The global Gitelman syndrome market was valued at USD 286.4 million in 2025 and is projected to reach USD 309.9 million in 2026, expanding to approximately USD 582.2 million by 2034, growing at a CAGR of 8.2% during the forecast period (2026-2034).
Read More
The global Glanzmann thrombasthenia market size was valued at USD 148.2 million in 2025 and is projected to reach USD 160.8 million in 2026, expanding to USD 311.1 million by 2034, growing at a CAGR of 8.6% during the forecast period (2026-2034).
Read More
The global Pompe disease market size was valued at USD 1.85 billion in 2025 and is estimated to reach USD 2.05 billion in 2026, expanding to USD 4.48 billion by 2034, growing at a CAGR of 10.2% during the forecast period (2026-2034).
Read More
The global Prader-Willi syndrome (PWS) market size was valued at USD 1.5 billion in 2025 and is projected to reach USD 1.65 billion in 2026, expanding to USD 3.4 billion by 2034, growing at a CAGR of 9.5% during the forecast period (2026-2034).
Read More
The global progressive supranuclear palsy market was valued at USD 231 million in 2025 and is projected to reach USD 313 million in 2026, expanding to USD 550 million by 2034, growing at a CAGR of 10.4% during the forecast period (2026-2034).
Read More
The global pyruvate kinase deficiency market size was valued at USD 0.85 billion in 2025 and is projected to reach USD 0.98 billion in 2026, expanding to USD 1.99 billion by 2035, growing at a CAGR of 7.32% during the forecast period (2026-2034).
Read More
The global Rett syndrome market size was valued at USD 485.5 million in 2025 and is projected to reach USD 541.3 million in 2026, expanding to USD 1,295.4 million by 2034, growing at a CAGR of 11.5% during the forecast period (2026–2034).
Read More
The global Sandhoff disease market size was valued at USD 274.95 million in 2025 and is projected to reach USD 456.42 million by 2034, expanding at a CAGR of 5.75% during the forecast period (2026-2034).
Read More
The global Sanfilippo syndrome (MPS III) market size was valued at USD 218.6 million in 2025 and is projected to reach USD 248.3 million in 2026, expanding to USD 713.5 million by 2034, growing at a CAGR of 14.1% during the forecast period (2026-2034).
Read More
The global stiff person syndrome market was valued at USD 127.5 million across major markets (US, EU4, UK, and Japan) in 2025 and is projected to reach USD 254.9 million by 2034, growing at a CAGR of 6.31% during the forecast period (2026-2034).
Read More
The global Tay-Sachs disease market was valued at USD 2.81 billion in 2026 and is projected to reach USD 4.40 billion by 2033, expanding at a compound annual growth rate of 6.6% during the forecast period (2026-2033).
Read More
The global X-linked hypophosphatemia market was valued at USD 0.89 billion in 2025 and is projected to reach USD 0.96 billion in 2026, expanding to USD 1.43 billion by 2034, growing at a CAGR of 6.1% during the forecast period (2026-2034).
Read More
The global glutaric aciduria type 1 (GA1) market was valued at USD 185 million in 2025 and is estimated to reach USD 203 million in 2026, expanding to approximately USD 415 million by 2034, registering a compound annual growth rate of around 9.3% during the forecast period (2026-2034).
Read More
The global alpha-1 antitrypsin deficiency market was valued at USD 3.1 billion in 2025 and is projected to reach USD 3.4 billion in 2026, expanding to USD 5.8 billion by 2034, growing at a CAGR of 8.4% during the forecast period (2026-2034).
Read More
The global Batten disease market was valued at USD 380 million in 2025 and is estimated to reach USD 420 million in 2026, expanding to approximately USD 950 million by 2034, growing at a CAGR of 10.7% during the forecast period (2026-2034).
Read More
The global congenital adrenal hyperplasia market size was valued at USD 0.56 billion in 2025 and is projected to expand to USD 1.08 billion by 2035, growing at a compound annual growth rate of 6.79% during the forecast period (2025-2035).
Read More
The global fibrodysplasia ossificans progressiva treatment market was valued at USD 0.54 billion in 2026 and is projected to expand at a compound annual growth rate of 8.8% through 2034, reaching USD 0.76 billion by 2030 and potentially exceeding USD 1.2 billion by 2034.
Read More
The global Fragile X syndrome market size was valued at USD 142.54 million in 2025 and is projected to reach USD 206.39 million by 2032, with continued expansion anticipated through 2034, growing at a compound annual growth rate of 5.43% during the forecast period (2026-2034).
Read More
The global Friedreich’s ataxia market size was valued at USD 1.12 billion in 2025 and is projected to reach USD 1.58 billion in 2026, expanding to USD 2.86 billion by 2034, growing at a CAGR of 13.04% during the forecast period (2026-2034).
Read More
The global gastrointestinal stromal tumors (GIST) market was valued at USD 2.4 billion in 2025 and is estimated to reach USD 2.6 billion in 2026, expanding to approximately USD 4.8 billion by 2034, registering a compound annual growth rate of around 8.0% during the forecast period (2026-2034).
Read More
The global Gaucher disease market size was valued at USD 1.9 billion in 2025 and is projected to reach USD 2.05 billion in 2026, expanding to USD 3.4 billion by 2034, growing at a CAGR of 6.5% during the forecast period (2026-2034).
Read More
The global Alexander disease market was valued at USD 186.3 million in 2025 and is projected to reach USD 258.7 million by 2036, expanding at a compound annual growth rate of 2.94% during the forecast period (2026-2036).
Read More
Global Immunotherapy Drugs Market size was valued at USD 285.95 Billion in 2025 and is projected to reach USD 756.23 Billion by 2034, growing at a CAGR of 11.11% from 2025 to 2034 according to a new report by Intellectual Market Insights Research.
Read More
Global Gerd Drugs And Devices Market size was valued at USD 5.76 Billion in 2025 and is projected to reach USD 7.14 Billion by 2034, growing at a CAGR of 2.3% from 2025 to 2034 according to a new report by Intellectual Market Insights Research.
Read More
The global CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) market size was valued at USD 3.02 billion in 2025 and is projected to reach USD 3.34 billion in 2026, expanding to USD 5.28 billion by 2034, growing at a CAGR of 6.1% during the forecast period (2026-2034).
Read More
Global Digestive Health Products Market size was valued at USD 60.05 Billion in 2025 and is projected to reach USD 124.29 Billion by 2034, growing at a CAGR of 8.3% from 2025 to 2034 according to a new report by IMIR Market Research.
Read More
Global Laboratory Informatics Market size was valued at USD 4.05 Billion in 2025 and is projected to reach USD 8.22 Billion by 2034, growing at a CAGR of 8.2% from 2025 to 2034 according to a new report by Intellectual Market Insights Research.
Read More
Global Oncology Pharmaceuticals Market size was valued at USD 256.26 Billion in 2025 and is projected to reach USD 697.17 Billion by 2034 growing at a CAGR of 11.71% from 2025 to 2034 according to a new report by IMIR Market Research.
Read More
Global Oncolytic Virus Therapies Market size was valued at USD 222.25 Million in 2025 and is projected to reach USD 815.75 Million by 2034, growing at a CAGR of 15.23% from 2025 to 2034 according to a new report by Intellectual Market Insights Research.
Read More
Global Bioanalytical Testing Services Market size was valued at USD 5.2 Billion in 2025 and is projected to reach USD 12.37 Billion by 2034, growing at a CAGR of 9.51% from 2025 to 2034 according to a new report by Intellectual Market Insights Research.
Read More
Global Cryotherapy Market size was valued at USD 6.26 Billion in 2025 and is projected to reach USD 18.16 Billion by 2034, growing at a CAGR of 10.52% from 2025 to 2034 according to a new report by Intellectual Market Insights Research.
Read More
Global Animal Ultrasound Market size was valued at USD 539.23 Million in 2025 and is projected to reach USD 1.43 Billion by 2034, growing at a CAGR of 8.2% from 2025 to 2034 according to a new report by Intellectual Market Insights Research.
Read More
Global Personalized Therapy Biosimulation Market size was valued at USD 2.17 Billion in 2025 and is projected to reach USD 4.12 Billion by 2034, growing at a CAGR of 7.08% from 2025 to 2034 according to a new report by Intellectual Market Insights Research.
Read More
Global Embolotherapy Market size was valued at USD 3.69 Billion in 2025 and is projected to reach USD 7 Billion by 2034, growing at a CAGR of 7.2% from 2025 to 2034 according to a new report by Intellectual Market Insights Research.
Read More
